Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Morpholinylmercaptobenzothiazole: Overview.
- Formula / weight
- C11H12N2OS2 · 252.35 g/mol (avg)
- First approval
- United States, 2012
- Code names
- BRN 0191684 · CCRIS 4911 · EC 203-052-4 · USAF CY-7
Resolves to
Clinical / RWD
Structure
InChIKey
MHKLKWCYGIBEQF-UHFFFAOYSA-NSMILESC1CN(CCO1)SC1=NC2=CC=CC=C2S1What you can answer from here — as of August 31, 2026
Which companies are running trials of Morpholinylmercaptobenzothiazole, in which indications and phases, and which of those programs are still active?